Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.25.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Deficit [Member]
Beginning balance at Dec. 31, 2023 $ 236,198   $ 469,396   $ (233,237)
Beginning balance, Shares at Dec. 31, 2023   47,823,232      
Beginning Balance at Dec. 31, 2023       $ 39  
Common stock issuance 5,746   5,746    
Stock-based compensation 3,791   3,791    
Common stock issuance, Shares   258,070      
Net unrealized losses on available-for-sale securities (77)     (77)  
Issuance of common stock in connection with exercise of stock options 1,109   1,109    
Issuance of common stock in connection with exercise of stock options, Shares   167,813      
Net Income (Loss) (25,047)       (25,047)
Ending balance at Mar. 31, 2024 221,720   480,042   (258,284)
Ending Balance at Mar. 31, 2024       (38)  
Ending balance, Shares at Mar. 31, 2024   48,249,115      
Beginning balance at Dec. 31, 2023 236,198   469,396   (233,237)
Beginning balance, Shares at Dec. 31, 2023   47,823,232      
Beginning Balance at Dec. 31, 2023       $ 39  
Ending balance at Dec. 31, 2024 152,335 $ 1 501,435   (349,101)
Ending balance, Shares at Dec. 31, 2024   50,743,101      
Stock-based compensation 5,161   5,161    
Net Income (Loss) (35,943)       (35,943)
Ending balance at Mar. 31, 2025 $ 121,553 $ 1 $ 506,596   $ (385,044)
Ending balance, Shares at Mar. 31, 2025   50,743,101